WeVote
Log In

Bill

Bill

SB 2997

Relating to the scheduling of certain controlled substances in response to certain actions by the United States Food and Drug Administration.

89th Legislature (2025) Introduced by José Menéndez

Texas bill would automatically align state drug scheduling with FDA actions, bypassing individual legislative votes on substance reclassification.

Referred to Health & Human Services
#crimes--drugs(i0185) #health&humanservicescommission(v0177)
0
WeVote Research Nonpartisan
Bill Summary · SB 2997

Legislative bill overview

SB 2997 would allow Texas to automatically adjust its controlled substance scheduling in response to FDA actions, enabling the state to align drug classification laws with federal changes without requiring separate legislative action. The bill appears designed to create a mechanism for Texas drug scheduling to mirror federal determinations, reducing delays between federal and state regulatory changes.

Why is this important

Controlled substance scheduling directly affects criminal penalties, medical research access, and treatment options for patients. Currently, Texas must pass legislation to reclassify drugs, which can lag behind federal changes—this bill would accelerate that process but also potentially cede state-level decision-making authority to federal agencies without explicit legislative review.

Potential points of contention

  • State autonomy vs. federal alignment: Whether Texas should automatically defer to FDA scheduling decisions or maintain independent state authority to reach different conclusions
  • Public health prioritization: Disagreement over whether automatic federal alignment serves Texas public health needs, particularly for drugs with state-specific concerns or different usage patterns
  • Legislative oversight: Concerns that removing the requirement for legislative action reduces transparency and democratic input into what substances are criminalized in Texas

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.